The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.
Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback